The upcoming drugs CagriSema and retatrutide target multiple gut hormones and could cause twice as much weight loss than current treatments. But experts wonder how much is too much

Amy J. Sheer, University of Florida GLP-1 drugs have ushered in a new era in weight loss. In just a few years, medications such as semaglutide and tirzepatide, known by the brand names Ozempic, Wegovy,

The global obesity epidemic has spurred pharmaceutical companies to invest heavily in developing effective weight management solutions, leading to a surge in clinical trials for anti-obesity medications. Amid growing demand for such treatments, significant ...

After months of discussion, President Donald Trump’s new direct-to-consumer pharmaceutical site, TrumpRx, officially launched on Thursday 5. The site lists a plethora of drugs for all

‘It’s not an easy pill to take’: The first highly anticipated GLP-1 pill is here, but physicians aren’t sure it has the staying power of the injections

There's another fight brewing around GLP-1 drugs -- this time on the delivery side.

Eligible customers can fill prescriptions for the recently introduced Wegovy (semaglutide) tablets at prices starting as low as $149 per month. Injectable forms of Wegovy and Ozempic (semaglutide) are also available starting at $199 per month.

Novo Nordisk is facing "unprecedented" price pressures, "intensifying competition" and patents expiring.

Independent of FDA’s enhanced oversight, it’s clear that DTC promotion of weight loss drugs is having a moment, as companies go all in in pursuit of uptake expansion.